A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19Short communication Published on 2020-06-012022-10-05 Journal: Journal of critical care [Category] SARS, 치료법, [키워드] adhere approved article China Chloroquine clinical trial Clinical use consensus paper coronavirus coronavirus disease COVID-19 effective Effectiveness Efficacy and safety Emergency Evidence in vitro In-vitro indication International National Patient patients with COVID-19 Pneumonia public health emergency registry replication of SARS-CoV-2 Research Result Safety SARS-CoV-2 searched systematic review the disease Treatment Trial Unregistered virus World Health Organization [DOI] 10.1016/j.jcrc.2020.03.005 [Article Type] Short communication
A real-time dashboard of clinical trials for COVID-19코로나19 임상시험 실시간 대시보드Article Published on 2020-06-012022-09-11 Journal: International Journal of Environmental Research an [Category] SARS, 임상, 치료제, [키워드] clinical trial COVID-19 [DOI] 10.1016/S2589-7500(20)30086-8 PMC 바로가기 [Article Type] Article
3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trialsCorrespondence Published on 2020-06-012022-10-05 Journal: Pharmacological research [Category] SARS, 임상, [키워드] 3CLpro clinical trial Evidence inhibitor therapeutic option [DOI] 10.1016/j.phrs.2020.104779 [Article Type] Correspondence
Repurposing chlorpromazine to treat COVID-19: The reCoVery studyResearch article Published on 2020-06-012022-10-05 Journal: L'Encéphale [Category] SARS, 신약개발, [키워드] alleviate Anti-SARS-CoV-2 Activity antiviral activity antiviral properties biodistribution blind Brain caused chlorpromazine Clathrin-mediated endocytosis clinical trial contagiousness Course COVID-19 COVID-19 infection COVID-19 pandemic CPZ developmental exhibit form France ICU care incidence individuals Infection lung multicenter neuroscience objective observation offer Paris Patient Prophylactic PROTECT psychotropic drug Randomized Recentin reduce reported repurposing Repurposing of molecules Respiratory Support Saliva SARS-CoV-2 severity Side effects standard treatment symptomatic therapeutic therapy Tolerance treat Trial virulent [DOI] 10.1016/j.encep.2020.05.006 [Article Type] Research article
Type 1 interferons as a potential treatment against COVID-19Short communication Published on 2020-06-012022-10-05 Journal: Antiviral Research [Category] SARS, 치료법, [키워드] antiviral activity clinical trial concerning COVID-19 evaluated in vitro interferon MERS-CoV Potential treatment Preliminary data SARS-CoV-2 treat Treatment Type type 1 interferon [DOI] 10.1016/j.antiviral.2020.104791 [Article Type] Short communication
An evidence mapping and analysis of registered COVID-19 clinical trials in ChinaResearch Article Published on 2020-06-012022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] “COVID-19 2019 novel coronavirus Analysis antiviral drug antiviral drugs CCT Characteristics China Chinese clinical Clinical data clinical trial collected Control COVID-19 COVID-19 outbreak Critical current distributions division drugs evaluate evaluated Evidence experimental group Glaxo Hypothesis identify imperative information interquartile range Intervention majority median Medicine nucleic acid Patient performed pilot study platform primary endpoints Primary outcome Primary outcomes public health recruit Registered registry Research Result Sample size severity Smith Study design TCM the disease therapy Traditional Trial trials variety WHO WHO ICTRP [DOI] 10.1186/s12916-020-01612-y PMC 바로가기 [Article Type] Research Article
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptableEditorial Published on 2020-06-012022-10-05 Journal: Radiotherapy and oncology : journal of the Europea [Category] 임상, [키워드] clinical trial Pneumonia radiation therapy risk treatment for COVID-19 [DOI] 10.1016/j.radonc.2020.04.060 [Article Type] Editorial
Clinical trial analysis of 2019-nCoV therapy registered in ChinaReview Published on 2020-06-012023-07-13 Journal: Journal of medical virology [Category] SARS, [키워드] China clinical trial New coronavirus pneumonia new drugs. [DOI] 10.1002/jmv.25733 PMC 바로가기 [Article Type] Review
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronavirusesReview article Published on 2020-06-012022-10-05 Journal: One Health [Category] 치료제, [키워드] accumulate Antiviral antiviral drug Antiviral effect approved clinical trial clinical trials Community compassionate use coronavirus coronavirus disease Coronaviruses COVID-19 current demonstrated Epidemics Evidence GS-441524 GS-5734 illness imperative in vitro in vivo information International knowledge mitigate one health pandemic pandemic progresses Potential treatment Practitioner public health recent Regulatory Remdesivir SARS-CoV-2 tested therapeutic option Therapies Treatment Vaccine development [DOI] 10.1016/j.onehlt.2020.100128 [Article Type] Review article
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency DepartmentEndemic Infections Published on 2020-05-312022-10-28 Journal: Western Journal of Emergency Medicine [Category] COVID-19, MERS, SARS, [키워드] addition clinical trial death Department discharged drug effective Emergency evaluate expected healthcare hospital initiated Other Patient Phase 1 Potential Prophylactic PROTECT receive recipient SARS-CoV-2 specific treatment supportive care The United States Treatment Vaccine [DOI] 10.5811/westjem.2020.3.47328 PMC 바로가기 [Article Type] Endemic Infections